Xiao-Fang Yu

Title: Innovations of Inventor Xiao-Fang Yu

Introduction

Xiao-Fang Yu is a notable inventor based in Baltimore, MD, who has made significant contributions to the field of antiviral research. With a total of two patents to his name, his work focuses on innovative methods to combat viral infections, particularly those caused by lentiviruses such as HIV.

Latest Patents

One of his latest patents is titled "Method of inhibiting lentiviral infectivity utilizing zinc chelation to inhibit Vif activity." This invention relates to a method for inhibiting the infectivity of lentiviruses by using a membrane-permeable zinc chelator. The method ensures that the antiviral-effective amount of the chelator does not substantially inhibit other zinc-binding proteins in the cell. Additionally, he has developed a patent for a "Method for reducing HIV viral budding by administering a VPS28-specific antibody that disrupts Gag-TSG101-VPS28 binding interactions." This invention highlights the importance of the interaction between TSG101 and Vps28 in the release of HIV-1 and proposes agents that can modulate this interaction for therapeutic purposes.

Career Highlights

Xiao-Fang Yu has worked with prestigious institutions such as The Johns Hopkins University and Functional Genetics, Inc. His research has contributed to the understanding of viral mechanisms and potential therapeutic interventions.

Collaborations

Throughout his career, he has collaborated with notable colleagues, including Bindong Liu and Limin Li, who have also contributed to advancements in the field of antiviral research.

Conclusion

Xiao-Fang Yu's innovative work in developing methods to inhibit lentiviral infectivity showcases his commitment to advancing antiviral therapies. His contributions are significant in the ongoing fight against viral infections, particularly HIV.